ArticleFrontiers in immunology2025

Case report: Patients with positive HER-2 amplification locally advanced gastroesophageal junction cancer achieved pathologic complete response with the addition of pembrolizumab to chemotherapy plus trastuzumab as neoadjuvant therapy.

Huanhuan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.